Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

What 3 Analyst Ratings Have To Say About Blueprint Medicines

Blueprint Medicines (NASDAQ:BPMC) has observed the following analyst ratings within the last quarter:

Benzinga

Where Luminar Technologies Stands With Analysts

Within the last quarter, Luminar Technologies (NASDAQ:LAZR) has observed the following analyst ratings:

Benzinga

Looking Into Lululemon Athletica's Recent Short Interest

Lululemon Athletica's (NASDAQ:LULU) short percent of float has risen 26.13% since its last report. The company recently reported that it has 2.80 million shares sold short, which is 2.51% of all regular shares that are available for trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyst Ratings for Northern Trust

Analysts have provided the following ratings for Northern Trust (NASDAQ:NTRS) within the last quarter:

Benzinga

Tractor Supply's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from Tractor Supply (NASDAQ:TSCO).

Benzinga

Teradyne: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Teradyne (NASDAQ:TER).

Benzinga

H&E Equipment Servs: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from H&E Equipment Servs (NASDAQ:HEES).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Are Nasdaq Stocks Now Reasonably Priced?

Over the past two years, technology companies have enjoyed explosive growth as investors were upbeat about the prospects for the sector at a time when people relied on technology to stay connected while cooped up in their homes.

Benzinga

Rocket Pharma's Gene Therapy Shows 100% Overall Survival In Immune Deficiency Disorder

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) has announced topline safety and efficacy data from its Phase 2 trial of RP-L201 gene therapy in severe Leukocyte Adhesion Deficiency-I (LAD-I). Data were shared at the American Society of Gene and Cell Therapy. LAD-I is a disorder that causes the immune system to malfunction, resulting in immunodeficiency. Immunodeficiencies…

Benzinga

What To Watch For In Microsoft Stock As Fed's Monetary Policy Spooks Investors

Microsoft Corporation (NASDAQ: MSFT) spiked up about 1% higher on Thursday morning after a bearish day on Wednesday saw the tech giant slide almost 5%. Stocks in the broader technology sector have been hammered over recent weeks, leading the S&P 500 down over 15% since March 29.

Benzinga

Why Clene Shares Are Rising

Clene Inc. (NASDAQ: CLNN) shares are trading higher by 10.81% at $2.46 after the company received a $3 million loan from the Maryland Board of Public Works to support production for its lead drug candidate CNM-Au8.

Benzinga

Canaan Registers Upbeat Q1; Aims To Navigate Through Bitcoin Price Fluctuation

Canaan Inc (NASDAQ:CAN) reported first-quarter FY22 revenue growth of 236.7% year-on-year to $213.9 million. Earnings per ADS were $0.41. The Y/Y increase was mainly attributable to the rise in total computing power sold and the average selling price per Thash/s. Total computing power sold increased 119.1% Y/Y to 4.3 million Thash/s. Canaan held…

Benzinga

Read Why Did Tricida Stop VALOR-CKD Renal Outcomes Trial Early

Tricida Inc (NASDAQ:TCDA) said that, as anticipated, it is stopping its VALOR-CKD renal outcomes trial early for administrative reasons under the existing study protocol to allow for six months of financial runway following topline results, currently anticipated in early Q4 2022. VALOR-CKD trial, initiated in 2018, was designed to evaluate veverimer's ability to…

Benzinga

This Sugarbeet Cooperative Looks To Overcome Truck Driver Shortage - Read How Kratos Helps

Kratos Defense & Security Solutions, Inc (NASDAQ:KTOS) has teamed with the Minn-Dak Farmers Cooperative (MDFC) to launch self-driving trucks, easing the truck driver shortage burden using Kratos Autonomous Systems. MDFC is a farmer-owned sugarbeet cooperative headquartered in Wahpeton, North Dakota. The collaboration combines Kratos' unmanned system technologies with Minn-Dak's agriculture and transportation expertise.…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Mid-Morning Market Update: Markets Open Lower; US Jobless Claims Increase To 218,000

U.S. stocks traded lower this morning, with the Dow Jones dipping more than 300 points on Thursday.

Benzinga

Why NeuroMetrix Shares Are Skyrocketing

NeuroMetrix Inc (NASDAQ: NURO) shares are trading higher by 30.10% at $4.06 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

Benzinga

Palo Alto Networks Whale Trades For May 19

Someone with a lot of money to spend has taken a bearish stance on Palo Alto Networks (NASDAQ:PANW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Universal Debuts Trailer For 'Bros,' First Gay Rom-Com From A Hollywood Studio

Comcast Corp.’s (NASDAQ: CMCSA) Universal Pictures has released a trailer for “Bros,” the first gay romantic comedy that is going into a nationwide theatrical release by a major Hollywood studio.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

FTX US Launches Stock Trading: What Traders And Investors Need To Know

Cryptocurrency exchange FTX is making the leap into U.S. equity trading.

Benzinga

Shares of cryptocurrency-related company Canaan Inc - ADR (NASDAQ: CAN) are trading higher by 16.24% at $3.65 after the company reported first-quarter earnings results.

Benzinga

5 Analysts Have This to Say About Sumo Logic

Sumo Logic (NASDAQ:SUMO) has observed the following analyst ratings within the last quarter:

Benzinga

Expert Ratings for Sarepta Therapeutics

Analysts have provided the following ratings for Sarepta Therapeutics (NASDAQ:SRPT) within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2022

Upgrades

Benzinga

5 Analysts Have This to Say About GDS Holdings

GDS Holdings (NASDAQ:GDS) has observed the following analyst ratings within the last quarter:

Benzinga

Analog Devices's Return on Invested Capital Overview

According to Benzinga Pro, during Q2, Analog Devices (NASDAQ:ADI) earned $783.27 million, a 179.66% increase from the preceding quarter. Analog Devices also posted a total of $2.97 billion in sales, a 10.73% increase since Q1.

1 … 530 531 532 533

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

310 stories

PANW

220 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.